Trial intelligence / Profile preview

PRP in Knee Osteoarthritis

NCT04454164Phase 1Completed

Start
Jun 2018
Primary completion
Aug 2019
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of autologous platelet-rich plasma in knee osteoarthritis (OA) (4 arms). Primary endpoints: Visual Analogue Scale at 24 months, Knee injury and Osteoarthritis Outcome Score at 24 months and 2 more. Started Jun 2018; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04454164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04454164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call